{"id":13335,"date":"2015-05-14T15:32:00","date_gmt":"2015-05-14T15:32:00","guid":{"rendered":"https:\/\/www.commoncause.org\/articles\/allergan-latest-company-to-leave-alec-as-pressure-builds-on-pfizer\/"},"modified":"2015-05-14T15:32:00","modified_gmt":"2015-05-14T15:32:00","slug":"allergan-derniere-entreprise-a-quitter-alec-alors-que-la-pression-monte-sur-pfizer","status":"publish","type":"article","link":"https:\/\/www.commoncause.org\/fr\/articles\/allergan-latest-company-to-leave-alec-as-pressure-builds-on-pfizer\/","title":{"rendered":"Allergan, derni\u00e8re entreprise \u00e0 quitter ALEC alors que la pression monte sur Pfizer"},"template":"","class_list":["post-13335","article","type-article","status-publish","hentry","article_type-blog-post"],"acf":{"details":{"summary":"Another major corporation has decided to leave the controversial corporate lobbying group the American Legislative Exchange Council (ALEC), Common Cause has learned.","featured_image":null,"article_type":1103,"authors":["{\"site_id\":\"1\",\"post_type\":\"person\",\"post_id\":8296}"],"related_issues":false,"related_work":false,"location":null},"sidebar":{"helper_enable_sidebar":false,"helper_media_contact":{"heading":"Media Contact","manually_enter_person":false,"person":null,"name":"","role":"","phone":"","email":""},"helper_links_downloads":{"heading":"Links & Downloads","links":null}},"page_layout":[{"acf_fc_layout":"layout_wysiwyg","_acfe_flexible_toggle":null,"component_wysiwyg":{"content":"

Une autre grande entreprise a d\u00e9cid\u00e9 de quitter le groupe de pression controvers\u00e9 American Legislative Exchange Council (ALEC), a appris Common Cause.<\/strong><\/p>

Allergan, une soci\u00e9t\u00e9 pharmaceutique de 14,4 milliards de dollars r\u00e9cemment acquise par Actavis, a d\u00e9clar\u00e9 \u00e0 Common Cause qu'elle \u00ab n'est plus un membre actif de l'ALEC \u00bb. pr\u00e9c\u00e9demment<\/a> Copr\u00e9sident de l'ALEC au Tennessee et membre du groupe de travail sur la sant\u00e9 et les services sociaux de l'ALEC. Les dossiers montrent qu'Allergan \u00e9tait \u00e9galement auparavant un principal bailleur de fonds<\/a> du fonds de \u00ab bourses \u00bb de l'ALEC, une caisse noire secr\u00e8te d'entreprise gr\u00e2ce \u00e0 laquelle les politiciens peuvent obtenir des voyages gratuits pour assister aux r\u00e9unions de l'ALEC.<\/p>

Le d\u00e9part de la soci\u00e9t\u00e9 intervient alors que la pression s'accro\u00eet sur le g\u00e9ant pharmaceutique Pfizer pour qu'il mette fin \u00e0 son adh\u00e9sion \u00e0 l'ALEC. En mars, plus de 80 organisations ont envoy\u00e9 aux dirigeants de Pfizer une lettre lettre<\/a> exhortant la soci\u00e9t\u00e9 \u00e0 quitter ALEC. Chez Pfizer assembl\u00e9e g\u00e9n\u00e9rale annuelle des actionnaires en avril<\/a>Les investisseurs et les d\u00e9fenseurs de l\u2019int\u00e9r\u00eat public ont de nouveau appel\u00e9 l\u2019entreprise \u00e0 mettre fin \u00e0 son adh\u00e9sion \u00e0 l\u2019ALEC et \u00e0 divulguer davantage de ses d\u00e9penses politiques et de lobbying.<\/p>

Cette semaine seulement, Common Cause et le Center for Media and Democracy a d\u00e9pos\u00e9 de nouvelles preuves aupr\u00e8s de l'IRS<\/a> concernant le statut d'organisme de bienfaisance \u00e0 but non lucratif d'ALEC et ses activit\u00e9s de lobbying ill\u00e9gales, qui comprenait une lettre de Pfizer soulignant comment la soci\u00e9t\u00e9 utilise ALEC pour faire avancer la l\u00e9gislation. Pfizer a d\u00e9clar\u00e9<\/a> elle est en d\u00e9saccord avec l'ALEC sur le changement climatique et est membre de l'ALEC pour travailler sp\u00e9cifiquement sur les questions de politique de sant\u00e9, la lettre de Pfizer a \u00e9galement r\u00e9v\u00e9l\u00e9 que la soci\u00e9t\u00e9 a rejoint un comit\u00e9 de l'environnement et de l'\u00e9nergie de l'ALEC pour travailler sur les questions de changement climatique au sein de l'ALEC en 2014. <\/p>

<\/strong>Common Cause continues to call on Pfizer to leave ALEC -- join us!<\/strong><\/a><\/p>

Allergan rejoint ainsi de nombreuses soci\u00e9t\u00e9s pharmaceutiques qui ont rompu leurs liens avec ALEC ces derni\u00e8res ann\u00e9es, notamment Johnson & Johnson, GlaxoSmithKline, Merck, Bristol-Myers Squibb et Sanofi. Au cours de l\u2019ann\u00e9e derni\u00e8re, ALEC a d\u00fb faire face \u00e0 un exode d\u2019entreprises, car de nombreuses soci\u00e9t\u00e9s ont rompu leurs liens avec l\u2019organisation en raison de sa position controvers\u00e9e sur les questions de changement climatique et de pr\u00e9occupations juridiques concernant son statut d\u2019organisme caritatif \u00e0 but non lucratif. Microsoft, Google, Facebook, Yelp, Yahoo, International Paper, Occidental Petroleum, News Corp, SAP, AOL, eBay, Northrop Grumman, BP et T-Mobile ont tous confirm\u00e9 qu\u2019ils avaient quitt\u00e9 ALEC ou pr\u00e9voyaient de le faire au cours des dix derniers mois.<\/p>

 Avec votre aide, Pfizer sera le prochain !<\/strong><\/a>
<\/strong><\/p>"}}]},"yoast_head":"\nAllergan Latest Company to Leave ALEC as Pressure Builds on Pfizer - Common Cause<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.commoncause.org\/fr\/articles\/allergan-derniere-entreprise-a-quitter-alec-alors-que-la-pression-monte-sur-pfizer\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Allergan Latest Company to Leave ALEC as Pressure Builds on Pfizer\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.commoncause.org\/fr\/articles\/allergan-derniere-entreprise-a-quitter-alec-alors-que-la-pression-monte-sur-pfizer\/\" \/>\n<meta property=\"og:site_name\" content=\"Common Cause\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/CommonCause\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.commoncause.org\/wp-content\/uploads\/2024\/10\/CC-Share-Graphic-Main9.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"630\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@CommonCause\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.commoncause.org\/articles\/allergan-latest-company-to-leave-alec-as-pressure-builds-on-pfizer\/\",\"url\":\"https:\/\/www.commoncause.org\/articles\/allergan-latest-company-to-leave-alec-as-pressure-builds-on-pfizer\/\",\"name\":\"Allergan Latest Company to Leave ALEC as Pressure Builds on Pfizer - Common Cause\",\"isPartOf\":{\"@id\":\"https:\/\/www.commoncause.org\/#website\"},\"datePublished\":\"2015-05-14T15:32:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.commoncause.org\/articles\/allergan-latest-company-to-leave-alec-as-pressure-builds-on-pfizer\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.commoncause.org\/articles\/allergan-latest-company-to-leave-alec-as-pressure-builds-on-pfizer\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.commoncause.org\/articles\/allergan-latest-company-to-leave-alec-as-pressure-builds-on-pfizer\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.commoncause.org\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Allergan Latest Company to Leave ALEC as Pressure Builds on Pfizer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.commoncause.org\/#website\",\"url\":\"https:\/\/www.commoncause.org\/\",\"name\":\"Common Cause\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.commoncause.org\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.commoncause.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.commoncause.org\/#organization\",\"name\":\"Common Cause\",\"url\":\"https:\/\/www.commoncause.org\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.commoncause.org\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.commoncause.org\/wp-content\/uploads\/2024\/05\/Common-Cause-Logo.png\",\"contentUrl\":\"https:\/\/www.commoncause.org\/wp-content\/uploads\/2024\/05\/Common-Cause-Logo.png\",\"width\":2066,\"height\":331,\"caption\":\"Common Cause\"},\"image\":{\"@id\":\"https:\/\/www.commoncause.org\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/CommonCause\",\"https:\/\/x.com\/CommonCause\",\"https:\/\/www.instagram.com\/ourcommoncause\/\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Allergan, derni\u00e8re entreprise \u00e0 quitter ALEC alors que la pression monte sur Pfizer - Common Cause","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.commoncause.org\/fr\/articles\/allergan-derniere-entreprise-a-quitter-alec-alors-que-la-pression-monte-sur-pfizer\/","og_locale":"fr_FR","og_type":"article","og_title":"Allergan Latest Company to Leave ALEC as Pressure Builds on Pfizer","og_url":"https:\/\/www.commoncause.org\/fr\/articles\/allergan-derniere-entreprise-a-quitter-alec-alors-que-la-pression-monte-sur-pfizer\/","og_site_name":"Common Cause","article_publisher":"https:\/\/www.facebook.com\/CommonCause","og_image":[{"width":1200,"height":630,"url":"https:\/\/www.commoncause.org\/wp-content\/uploads\/2024\/10\/CC-Share-Graphic-Main9.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@CommonCause","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.commoncause.org\/articles\/allergan-latest-company-to-leave-alec-as-pressure-builds-on-pfizer\/","url":"https:\/\/www.commoncause.org\/articles\/allergan-latest-company-to-leave-alec-as-pressure-builds-on-pfizer\/","name":"Allergan, derni\u00e8re entreprise \u00e0 quitter ALEC alors que la pression monte sur Pfizer - Common Cause","isPartOf":{"@id":"https:\/\/www.commoncause.org\/#website"},"datePublished":"2015-05-14T15:32:00+00:00","breadcrumb":{"@id":"https:\/\/www.commoncause.org\/articles\/allergan-latest-company-to-leave-alec-as-pressure-builds-on-pfizer\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.commoncause.org\/articles\/allergan-latest-company-to-leave-alec-as-pressure-builds-on-pfizer\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.commoncause.org\/articles\/allergan-latest-company-to-leave-alec-as-pressure-builds-on-pfizer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.commoncause.org\/"},{"@type":"ListItem","position":2,"name":"Allergan Latest Company to Leave ALEC as Pressure Builds on Pfizer"}]},{"@type":"WebSite","@id":"https:\/\/www.commoncause.org\/#website","url":"https:\/\/www.commoncause.org\/","name":"Cause commune","description":"","publisher":{"@id":"https:\/\/www.commoncause.org\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.commoncause.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.commoncause.org\/#organization","name":"Cause commune","url":"https:\/\/www.commoncause.org\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.commoncause.org\/#\/schema\/logo\/image\/","url":"https:\/\/www.commoncause.org\/wp-content\/uploads\/2024\/05\/Common-Cause-Logo.png","contentUrl":"https:\/\/www.commoncause.org\/wp-content\/uploads\/2024\/05\/Common-Cause-Logo.png","width":2066,"height":331,"caption":"Common Cause"},"image":{"@id":"https:\/\/www.commoncause.org\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/CommonCause","https:\/\/x.com\/CommonCause","https:\/\/www.instagram.com\/ourcommoncause\/"]}]}},"distributor_meta":false,"distributor_terms":false,"distributor_media":false,"distributor_original_site_name":"Common Cause","distributor_original_site_url":"https:\/\/www.commoncause.org\/fr","push-errors":false,"_links":{"self":[{"href":"https:\/\/www.commoncause.org\/fr\/wp-json\/wp\/v2\/article\/13335","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.commoncause.org\/fr\/wp-json\/wp\/v2\/article"}],"about":[{"href":"https:\/\/www.commoncause.org\/fr\/wp-json\/wp\/v2\/types\/article"}],"version-history":[{"count":0,"href":"https:\/\/www.commoncause.org\/fr\/wp-json\/wp\/v2\/article\/13335\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.commoncause.org\/fr\/wp-json\/wp\/v2\/media?parent=13335"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}